On Wednesday, Cathie Wood-led Ark Invest made significant trades, notably involving Tempus AI Inc (NASDAQ:TEM) and Meta Platforms Inc (NASDAQ:META). These trades reflect Ark’s strategic adjustments amidst evolving market conditions and company-specific developments.
The Tempus AI Trade
ARK Genomic Revolution ETF (BATS:ARKG) and ARK Space & Defense Innovation ETF (BATS:ARKK) increased their holdings in Tempus AI by acquiring 12,649 and 72,290 shares, respectively. The shares closed at $46.76, marking a 4.24% decline.
This purchase aligns with Tempus’ recent collaboration with Daiichi Sankyo, aiming to enhance AI-driven biomarker discovery in oncology. The collaboration seeks to leverage AI models for patient selection, potentially boosting the success rate of new treatments. The total value of the shares bought by Ark Invest in Tempus AI is approximately $3.97 million.
The Meta Platforms Trade
ARK Blockchain & Fintech Innovation ETF (BATS:ARKF), ARK Next Generation Internet ETF
This post was originally published here